应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06628 创胜集团-B
交易中 04-19 14:50:58
1.610
+0.010
+0.63%
最高
1.800
最低
1.600
成交量
9,000
今开
1.800
昨收
1.600
日振幅
12.50%
总市值
7.03亿
流通市值
7.03亿
总股本
4.36亿
成交额
1.49万
换手率
0.00%
流通股本
4.36亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
创胜集团-B(06628)4月18日回购3500股
智通财经网 · 04-18 19:44
创胜集团-B(06628)4月18日回购3500股
创胜集团-B盘中异动 股价大跌5.81%报1.460港元
自选股智能写手 · 04-18 11:23
创胜集团-B盘中异动 股价大跌5.81%报1.460港元
创胜集团-B(06628)4月17日斥资4.27万港元回购3.05万股
智通财经网 · 04-17 18:48
创胜集团-B(06628)4月17日斥资4.27万港元回购3.05万股
创胜集团-B盘中异动 股价大涨6.54%
自选股智能写手 · 04-17 13:38
创胜集团-B盘中异动 股价大涨6.54%
创胜集团-B(06628)股价上升6.618%,现价港币$1.45
阿斯达克财经 · 04-17 13:38
创胜集团-B(06628)股价上升6.618%,现价港币$1.45
创胜集团-B(06628)4月16日斥资6.29万港元回购4.95万股
智通财经 · 04-16 19:54
创胜集团-B(06628)4月16日斥资6.29万港元回购4.95万股
创胜集团-B(06628)股价显著波动13.386%,现价港币$1.33
阿斯达克财经 · 04-16 15:55
创胜集团-B(06628)股价显著波动13.386%,现价港币$1.33
创胜集团-B(06628)股价上升7.087%,现价港币$1.36
阿斯达克财经 · 04-16
创胜集团-B(06628)股价上升7.087%,现价港币$1.36
创胜集团-B盘中异动 股价大跌5.51%报1.200港元
自选股智能写手 · 04-16
创胜集团-B盘中异动 股价大跌5.51%报1.200港元
创胜集团-B盘中异动 早盘股价大跌6.47%
自选股智能写手 · 04-15
创胜集团-B盘中异动 早盘股价大跌6.47%
创胜集团-B盘中异动 股价大跌8.29%报1.450港元
自选股智能写手 · 04-12
创胜集团-B盘中异动 股价大跌8.29%报1.450港元
创胜集团-B盘中异动 快速下挫6.92%
自选股智能写手 · 04-11
创胜集团-B盘中异动 快速下挫6.92%
创胜集团-B(06628)股价下跌6.977%,现价港币$1.6
阿斯达克财经 · 04-11
创胜集团-B(06628)股价下跌6.977%,现价港币$1.6
创胜集团-B盘中异动 早盘快速下挫5.56%
自选股智能写手 · 04-09
创胜集团-B盘中异动 早盘快速下挫5.56%
创胜集团宣布与安捷伦合作开发可支持Osemitamab(TST001)全球III期临床试验的Claudin18.2伴随诊断试剂盒
美通社 · 04-09
创胜集团宣布与安捷伦合作开发可支持Osemitamab(TST001)全球III期临床试验的Claudin18.2伴随诊断试剂盒
创胜集团-B(06628.HK)伙安捷伦科技进行胃癌治疗临床试验
阿斯达克财经 · 04-09
创胜集团-B(06628.HK)伙安捷伦科技进行胃癌治疗临床试验
智通港股早知道 | 住建部推进建筑和市政基础设施设备更新 4月进口网络游戏版号下发
智通财经 · 04-09
智通港股早知道 | 住建部推进建筑和市政基础设施设备更新 4月进口网络游戏版号下发
创胜集团-B(06628)发布与安捷伦合作开发支持可Osemitamab (TST001)全球III期临床试验的CLDN18.2伴随诊断试剂的最新业务进展
智通财经 · 04-09
创胜集团-B(06628)发布与安捷伦合作开发支持可Osemitamab (TST001)全球III期临床试验的CLDN18.2伴随诊断试剂的最新业务进展
创胜集团-B盘中异动 下午盘股价大涨10.63%
自选股智能写手 · 04-08
创胜集团-B盘中异动 下午盘股价大涨10.63%
加载更多
公司概况
公司名称:
创胜集团-B
所属市场:
SEHK
上市日期:
--
主营业务:
创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的中国投资控股公司。该公司的产品包括MSB2311,TST001,TST005,TST002,TST004,TST003,TST008,MSB0254和TST006。该公司产品均处于研发阶段,尚未市场化。该公司还提供合同开发和生产(CDMO)服务,主要包括工艺开发服务、GMP/cGMP生产服务、细胞株开发服务、样品检测服务、配方优化服务及成药性研究。
发行价格:
--
{"stockData":{"symbol":"06628","market":"HK","secType":"STK","nameCN":"创胜集团-B","latestPrice":1.61,"timestamp":1713508331387,"preClose":1.6,"halted":0,"volume":9000,"delay":0,"floatShares":436375375,"shares":436375375,"eps":-1.22758,"marketStatus":"交易中","marketStatusCode":2,"change":0.01,"latestTime":"04-19 14:50:58","open":1.8,"high":1.8,"low":1.6,"amount":14850,"amplitude":0.125,"askPrice":1.7,"askSize":6000,"bidPrice":1.61,"bidSize":4000,"shortable":0,"etf":0,"ttmEps":-1.2275798933370923,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1713514200000},"adr":0,"listingDate":1632844800000,"adjPreClose":1.6,"openAndCloseTimeList":[[1713490200000,1713499200000],[1713502800000,1713513600000]],"volumeRatio":0.134638,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06628/","defaultTab":"news","newsList":[{"id":"2428567819","title":"创胜集团-B(06628)4月18日回购3500股","url":"https://stock-news.laohu8.com/highlight/detail?id=2428567819","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2428567819?lang=zh_cn&edition=full","pubTime":"2024-04-18 19:44","pubTimestamp":1713440653,"startTime":"0","endTime":"0","summary":"创胜集团-B(06628)发布公告,该公司于2024年4月18日斥资5099.85...","market":"us","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_39.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_39.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1104795.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428587302","title":"创胜集团-B盘中异动 股价大跌5.81%报1.460港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428587302","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428587302?lang=zh_cn&edition=full","pubTime":"2024-04-18 11:23","pubTimestamp":1713410620,"startTime":"0","endTime":"0","summary":"2024年04月18日早盘11时23分,创胜集团-B股票出现异动,股价大幅下跌5.81%。截至发稿,该股报1.460港元/股,成交量4500股,换手率0.00%,振幅3.23%。资金方面,该股资金流入0港元,流出5100港元。创胜集团-B股票所在的生物技术行业中,整体跌幅为0.03%。创胜集团-B公司简介:创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的中国投资控股公司。消息层面,截至11时23分,创胜集团-B股票正面舆情新闻比例25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041811234079216741&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041811234079216741&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428293313","title":"创胜集团-B(06628)4月17日斥资4.27万港元回购3.05万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2428293313","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2428293313?lang=zh_cn&edition=full","pubTime":"2024-04-17 18:48","pubTimestamp":1713350887,"startTime":"0","endTime":"0","summary":"智通财经APP讯,创胜集团-B(06628)发布公告,该公司于2024年4月17日斥资4.27万港元回购3.05万股,回购价为每股1.38港元-1.3992港元。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1104008.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428363838","title":"创胜集团-B盘中异动 股价大涨6.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428363838","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428363838?lang=zh_cn&edition=full","pubTime":"2024-04-17 13:38","pubTimestamp":1713332326,"startTime":"0","endTime":"0","summary":"2024年04月17日下午盘13时38分,创胜集团-B股票出现异动,股价大幅拉升6.54%。截至发稿,该股报1.450港元/股,成交量7.15万股,换手率0.02%,振幅6.62%。创胜集团-B股票所在的生物技术行业中,整体跌幅为0.04%。创胜集团-B公司简介:创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的中国投资控股公司。消息层面,截至13时38分,创胜集团-B股票正面舆情新闻比例33.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041713384779211f90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041713384779211f90&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428936356","title":"创胜集团-B(06628)股价上升6.618%,现价港币$1.45","url":"https://stock-news.laohu8.com/highlight/detail?id=2428936356","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428936356?lang=zh_cn&edition=full","pubTime":"2024-04-17 13:38","pubTimestamp":1713332280,"startTime":"0","endTime":"0","summary":"[上升股]创胜集团-B(06628) 股价在下午01:38比前收市价上升6.618%,现股价为港币$1.45。至目前为止,今日最高价为$1.45,而最低价为$1.36。总成交量为7.15万股,总成交金额为港币$10.02万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR240417877/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2427825815","title":"创胜集团-B(06628)4月16日斥资6.29万港元回购4.95万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2427825815","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427825815?lang=zh_cn&edition=full","pubTime":"2024-04-16 19:54","pubTimestamp":1713268448,"startTime":"0","endTime":"0","summary":"智通财经APP讯,创胜集团-B(06628)发布公告,于2024年4月16日该公司斥资6.29万港元回购4.95万股,回购价格为每股1.2000-1.2715港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1103495.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427140408","title":"创胜集团-B(06628)股价显著波动13.386%,现价港币$1.33","url":"https://stock-news.laohu8.com/highlight/detail?id=2427140408","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427140408?lang=zh_cn&edition=full","pubTime":"2024-04-16 15:55","pubTimestamp":1713254100,"startTime":"0","endTime":"0","summary":"[异动股]创胜集团-B(06628) 股价在下午03:55出现显著波动13.386%,现股价为港币$1.33,比前收市价上升4.724%4.724%。至目前为止,今日最高价为$1.36,而最低价为$1.19。总成交量为6.209万股,总成交金额为港币$7.753万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112134428668_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112134428668_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAC240416132/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2427891631","title":"创胜集团-B(06628)股价上升7.087%,现价港币$1.36","url":"https://stock-news.laohu8.com/highlight/detail?id=2427891631","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427891631?lang=zh_cn&edition=full","pubTime":"2024-04-16 13:14","pubTimestamp":1713244440,"startTime":"0","endTime":"0","summary":"[上升股]创胜集团-B(06628) 股价在下午01:14比前收市价上升7.087%,现股价为港币$1.36。至目前为止,今日最高价为$1.36,而最低价为$1.19。总成交量为6.109万股,总成交金额为港币$7.62万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404161468/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2427865669","title":"创胜集团-B盘中异动 股价大跌5.51%报1.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427865669","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427865669?lang=zh_cn&edition=full","pubTime":"2024-04-16 09:43","pubTimestamp":1713231780,"startTime":"0","endTime":"0","summary":"2024年04月16日早盘09时43分,创胜集团-B股票出现波动,股价急速下挫5.51%。截至发稿,该股报1.200港元/股,成交量5000股,换手率0.00%,振幅7.09%。资金方面,该股资金流入0港元,流出3000港元。最近的财报数据显示,该股实现营业收入5,942.16万港元,净利润-5.10亿港元,每股收益-1.26港元,毛利1,588.80万港元,市盈率-1.03倍。创胜集团-B股票所在的生物技术行业中,整体跌幅为0.31%。消息层面,截至09时43分,创胜集团-B股票正面舆情新闻比例50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416094301861e5f5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240416094301861e5f5a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427712016","title":"创胜集团-B盘中异动 早盘股价大跌6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427712016","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427712016?lang=zh_cn&edition=full","pubTime":"2024-04-15 10:58","pubTimestamp":1713149914,"startTime":"0","endTime":"0","summary":"2024年04月15日早盘10时58分,创胜集团-B股票出现波动,股价快速跳水6.47%。创胜集团-B股票所在的生物技术行业中,整体跌幅为0.72%。其相关个股中,乐普生物-B、和铂医药-B、方达控股涨幅较大,振幅较大的相关个股有科济药业-B、乐普生物-B、来凯医药-B,振幅分别为16.43%、11.75%、10.81%。创胜集团-B公司简介:创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041510583487e8054a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041510583487e8054a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426127945","title":"创胜集团-B盘中异动 股价大跌8.29%报1.450港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426127945","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426127945?lang=zh_cn&edition=full","pubTime":"2024-04-12 15:21","pubTimestamp":1712906505,"startTime":"0","endTime":"0","summary":"2024年04月12日下午盘15时21分,创胜集团-B股票出现波动,股价急速下挫8.29%。截至发稿,该股报1.450港元/股,成交量7500股,换手率0.00%,振幅6.33%。资金方面,该股资金流入775港元,流出7250港元。创胜集团-B股票所在的生物技术行业中,整体跌幅为0.09%。消息层面,截至15时21分,创胜集团-B股票正面舆情新闻比例20%。《创胜集团-B发布与安捷伦合作开发支持可Osemitamab 全球III期临床试验的CLDN18.2伴随诊断试剂的最新业务进展》资讯为影响创胜集团-B的重要信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041215214579201b2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041215214579201b2a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426470336","title":"创胜集团-B盘中异动 快速下挫6.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426470336","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426470336?lang=zh_cn&edition=full","pubTime":"2024-04-11 10:07","pubTimestamp":1712801223,"startTime":"0","endTime":"0","summary":"2024年04月11日早盘10时07分,创胜集团-B股票出现波动,股价急速下挫6.92%。创胜集团-B股票所在的生物技术行业中,整体跌幅为0.79%。消息层面,截至10时07分,《创胜集团-B发布与安捷伦合作开发支持可Osemitamab 全球III期临床试验的CLDN18.2伴随诊断试剂的最新业务进展》资讯为影响创胜集团-B的重要信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411100703791fccaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411100703791fccaf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426447035","title":"创胜集团-B(06628)股价下跌6.977%,现价港币$1.6","url":"https://stock-news.laohu8.com/highlight/detail?id=2426447035","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426447035?lang=zh_cn&edition=full","pubTime":"2024-04-11 10:07","pubTimestamp":1712801220,"startTime":"0","endTime":"0","summary":"[下跌股]创胜集团-B(06628) 股价在上午10:07比前收市价下跌6.977%,现股价为港币$1.6。至目前为止,今日最高价为$1.65,而最低价为$1.6。总成交量为4000股,总成交金额为港币$6575。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240411715/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2426745905","title":"创胜集团-B盘中异动 早盘快速下挫5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426745905","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426745905?lang=zh_cn&edition=full","pubTime":"2024-04-09 09:30","pubTimestamp":1712626208,"startTime":"0","endTime":"0","summary":"2024年04月09日早盘09时30分,创胜集团-B股票出现波动,股价快速下跌5.56%。创胜集团-B股票所在的生物技术行业中,整体跌幅为0.19%。创胜集团-B公司简介:创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的中国投资控股公司。消息层面,截至09时30分,《创胜集团-B发布与安捷伦合作开发支持可Osemitamab 全球III期临床试验的CLDN18.2伴随诊断试剂的最新业务进展》资讯为影响创胜集团-B的重要信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404090930087a517ec2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404090930087a517ec2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426905507","title":"创胜集团宣布与安捷伦合作开发可支持Osemitamab(TST001)全球III期临床试验的Claudin18.2伴随诊断试剂盒","url":"https://stock-news.laohu8.com/highlight/detail?id=2426905507","media":"美通社","top":-1,"share":"https://www.laohu8.com/m/news/2426905507?lang=zh_cn&edition=full","pubTime":"2024-04-09 09:10","pubTimestamp":1712625000,"startTime":"0","endTime":"0","summary":"创胜集团与伴随诊断开发领域的全球领导者安捷伦紧密合作,共同推进该抗体的进一步开发及其在伴随诊断试剂中的应用。安捷伦与创胜集团已在AACR年会上公布了Claudin18.2 IHC 14G11 pharmDx试剂的早期研究结果。Osemitamab 是全球范围内开发的第二个最先进的CLDN18.2靶向抗体药物,由本公司通过其免疫耐受突破技术平台开发。Osemitamab 通过ADCC机制杀死表达CLDN18.2的肿瘤细胞。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4381757_ZH81757_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426701379","title":"创胜集团-B(06628.HK)伙安捷伦科技进行胃癌治疗临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2426701379","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426701379?lang=zh_cn&edition=full","pubTime":"2024-04-09 08:38","pubTimestamp":1712623080,"startTime":"0","endTime":"0","summary":"创胜集团-B公布,与安捷伦科技合作开发Claudin18.2伴随诊断试剂,以支持Osemitamab联合纳武利尤单抗与化疗,作为CLDN18.2表达局部晚期或转移性胃或胃食管结合部腺癌患者一线治疗的TranStar301全球III期关键临床试验。该抗体是针对位于loop1细胞外域的线性表位生成,其结合位点与治疗性抗体Osemitamab 的结合位点重叠。公司将与伴随诊断开发领域的安捷伦紧密合作,共同推进抗体进一步开发及其在伴随诊断试剂中的应用。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220216154458577_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220216154458577_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1340822/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2426388974","title":"智通港股早知道 | 住建部推进建筑和市政基础设施设备更新 4月进口网络游戏版号下发","url":"https://stock-news.laohu8.com/highlight/detail?id=2426388974","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426388974?lang=zh_cn&edition=full","pubTime":"2024-04-09 07:54","pubTimestamp":1712620455,"startTime":"0","endTime":"0","summary":"住建部印发方案 推进建筑和市政基础设施设备更新工作智通财经APP获悉,近日,住建部印发《推进建筑和市政基础设施设备更新工作实施方案》。丰田或与华为合作共同打造智驾方案腾讯新闻4月7日报道称,丰田全球车型智能驾驶方案将采用“丰田+华为+Momenta”三方联合方案模式。据悉,该40亿港元贷款将于7月到期。其中,于中国实现包裹量39.42亿件,同比增加46.1%,日均包裹量4330万件。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1099733.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2426973070","title":"创胜集团-B(06628)发布与安捷伦合作开发支持可Osemitamab (TST001)全球III期临床试验的CLDN18.2伴随诊断试剂的最新业务进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2426973070","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426973070?lang=zh_cn&edition=full","pubTime":"2024-04-09 06:48","pubTimestamp":1712616527,"startTime":"0","endTime":"0","summary":"智通财经APP讯,创胜集团-B 发布公告,与安捷伦科技合作开发 Claudin18.2 伴随诊断试剂,以支持Osemitamab 联合纳武利尤单抗与化疗作为CLDN18.2表达的局部晚期或转移性胃或胃食管结合部腺癌患者一线治疗的TranStar301全球III期关键临床试验。安捷伦与公司已在AACR年会上公布了CLDN18.2 IHC 14G11 pharmDx试剂的早期研究结果。Osemitamab 是全球范围内开发的第二个最先进的 CLDN18.2靶向抗体药物,由公司通过其免疫耐受突破技术平台开发。Osemitamab 通过ADCC机制杀死CLDN18.2表达的肿瘤细胞。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1099723.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2425193701","title":"创胜集团-B盘中异动 下午盘股价大涨10.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2425193701","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425193701?lang=zh_cn&edition=full","pubTime":"2024-04-08 14:54","pubTimestamp":1712559242,"startTime":"0","endTime":"0","summary":"2024年04月08日下午盘14时54分,创胜集团-B股票出现异动,股价急速拉升10.63%。创胜集团-B股票所在的生物技术行业中,整体涨幅为0.90%。其相关个股中,康宁杰瑞制药-B、泰格医药、华领医药-B涨幅较大,振幅较大的相关个股有创胜集团-B、康宁杰瑞制药-B、金斯瑞生物科技,振幅分别为14.29%、14.18%、12.85%。创胜集团-B公司简介:创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的中国投资控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040814540387e7e7d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040814540387e7e7d2&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.transcenta.com","stockEarnings":[{"period":"1week","weight":0.0127},{"period":"1month","weight":-0.1919},{"period":"3month","weight":-0.5556},{"period":"6month","weight":-0.5918},{"period":"1year","weight":-0.5166},{"period":"ytd","weight":-0.5543}],"compareEarnings":[{"period":"1week","weight":-0.0415},{"period":"1month","weight":-0.0087},{"period":"3month","weight":0.0704},{"period":"6month","weight":-0.0458},{"period":"1year","weight":-0.1955},{"period":"ytd","weight":-0.0388}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"创胜集团医药有限公司是一家从事临床阶段生物制药的发现、研究、开发、制造和业务拓展的中国投资控股公司。该公司的产品包括MSB2311,TST001,TST005,TST002,TST004,TST003,TST008,MSB0254和TST006。该公司产品均处于研发阶段,尚未市场化。该公司还提供合同开发和生产(CDMO)服务,主要包括工艺开发服务、GMP/cGMP生产服务、细胞株开发服务、样品检测服务、配方优化服务及成药性研究。","exchange":"SEHK","name":"创胜集团-B","nameEN":"TRANSCENTA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"创胜集团-B(06628)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供创胜集团-B(06628)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"创胜集团-B,06628,创胜集团-B股票,创胜集团-B股票老虎,创胜集团-B股票老虎国际,创胜集团-B行情,创胜集团-B股票行情,创胜集团-B股价,创胜集团-B股市,创胜集团-B股票价格,创胜集团-B股票交易,创胜集团-B股票购买,创胜集团-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"创胜集团-B(06628)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供创胜集团-B(06628)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}